The global market for Blood Glucose Lancing Pen was valued at US$ 458 million in the year 2024 and is projected to reach a revised size of US$ 643 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Blood Glucose Lancing Pen Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Blood Glucose Lancing Pen competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

A blood glucose lancing pen is a portable device used for self-monitoring of blood glucose (SMBG) or point-of-care testing (POCT). It typically comprises a pen-style housing, replaceable or preloaded disposable lancets, an adjustable depth-control mechanism, and a trigger/spring activation system. The device is engineered to minimize pain and penetration depth while ensuring sufficient and consistent capillary blood volume for accurate glucose measurement by test strips or sensors. With the proliferation of chronic disease management, home healthcare and POCT, lancing pens have evolved from simple puncture tools into integrated consumable-platform components emphasizing ergonomics, infection control (single-use or retractable safety mechanisms), and data connectivity (integration with meters and mobile apps). Differentiated models target pediatric, geriatric, and sensitive-skin users with low-pain profiles and configurable depth settings. As the frontline interface in glucose monitoring workflows, the lancing pen is both a critical patient-facing device and a foundational consumable within the broader glucose-monitoring ecosystem (test strips/sensors, data platforms, clinical services).In 2024, global blood glucose lancing pen production reached approximately 57.21 m units, with an average global market price of around US$ 8 perunit.The average gross profit margin of this product is 45%.

The blood glucose lancing pen market is propelled by multiple long-term drivers: demographic aging and the growing burden of diabetes and metabolic disorders create persistent demand for home glucose self-monitoring and chronic disease management; healthcare delivery’s shift toward community and home care elevates the procurement priority for portable, user-friendly, and infection-mitigating sampling solutions; and digitization of diagnostics extends monitoring devices from standalone hardware into “device + data service” ecosystems, creating premium opportunities for pens with connectivity and superior user experience. Additionally, public health and regulatory emphasis on strengthening POCT capabilities opens procurement and reimbursement channels for compliant manufacturers. Corporate annual reports and governmental statements consistently point to an opportunity set where product upgrades emphasizing safety, comfort, and connectivity can materially improve brand pricing power and channel reach.

Challenges are evident: regulatory and safety requirements for needlestick devices and infection control are tightening in developed markets, raising time-to-market and compliance costs; commoditization of consumables drives price competition, squeezing margins; upstream supply volatility for materials and precision molds threatens production continuity and cost management; and rising consumer expectations for low-pain experiences and seamless data integration mean vendors lagging in UX or digital linkage risk losing channels and patient mindshare. These risk themes are reflected repeatedly in leading firms’ reports and regulatory guidance, underlining the need to balance compliance and innovation.

Downstream demand is stratified and scenario-driven: hospitals and clinics favor retractable, single-use solutions for multi-patient workflows to minimize cross-infection; home users prioritize portability, low pain and ease of use, with strong demand for meter/app interoperability; special populations (pediatrics, geriatrics, sensitive skin) drive demand for dedicated depth settings, finer gauges or microneedle options; and POCT and primary-care strengthening policies boost procurement at community levels—favoring compliant brands. Public health listings and corporate strategy disclosures indicate that integrated “service + device” offerings are more readily adopted by clinical and channel stakeholders, shifting procurement toward higher-value, traceable products.

The upstream supply base centers on medical-grade stainless steel, polypropylene (PP), polycarbonate (PC), medical silicone components and disposable plastics; material biocompatibility, processing consistency and surface treatment determine puncture performance and patient pain perception. Suppliers are consolidating toward partners that provide medical-grade consistency and greener formulations, enabling recyclable or low-carbon material use in packaging and non-contact parts. The emergence of microneedle and smart lancing pens elevates requirements for microfabrication, precision tooling and electronic components (micro-motors, Bluetooth modules), making supplier quality systems and industrial collaboration critical selection criteria for OEMs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Blood Glucose Lancing Pen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Glucose Lancing Pen.

The Blood Glucose Lancing Pen market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blood Glucose Lancing Pen market comprehensively. Regional market sizes, concerning products by Type, by Application, by Operation and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Blood Glucose Lancing Pen manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Operation and by regions.

Scope of Blood Glucose Lancing Pen Market Report

Report Metric	Details
Report Name	Blood Glucose Lancing Pen Market
Accounted market size in year	US$ 458 million
Forecasted market size in 2031	US$ 643 million
CAGR	5.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Adjustable Lancing Device Non-adjustable Lancing Device
Segment by Operation	Manual Lancing Pen Automatic Lancing Pen
Segment by Protection Mechanisms	Standard Pen Safety Lancing Pen
Segment by Application	Hospital Clinic Homecare Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Roche, Lifescan, Abbott, Ascensia, B. Braun, TERUMO, Sinocare, ARKRAY, GMMC Group, BIONIME, LIANFA, Lobeck Medical AG
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Blood Glucose Lancing Pen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Blood Glucose Lancing Pen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Blood Glucose Lancing Pen Market growing?

Ans: The Blood Glucose Lancing Pen Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Blood Glucose Lancing Pen Market size in 2031?

Ans: The Blood Glucose Lancing Pen Market size in 2031 will be US$ 643 million.

Who are the main players in the Blood Glucose Lancing Pen Market report?

Ans: The main players in the Blood Glucose Lancing Pen Market are Roche, Lifescan, Abbott, Ascensia, B. Braun, TERUMO, Sinocare, ARKRAY, GMMC Group, BIONIME, LIANFA, Lobeck Medical AG

What are the Application segmentation covered in the Blood Glucose Lancing Pen Market report?

Ans: The Applications covered in the Blood Glucose Lancing Pen Market report are Hospital, Clinic, Homecare, Other

What are the Type segmentation covered in the Blood Glucose Lancing Pen Market report?

Ans: The Types covered in the Blood Glucose Lancing Pen Market report are Adjustable Lancing Device, Non-adjustable Lancing Device

1 Blood Glucose Lancing Pen Market Overview

1.1 Product Definition

1.2 Blood Glucose Lancing Pen by Type

1.2.1 Global Blood Glucose Lancing Pen Market Value Comparison by Type (2024 VS 2031)

1.2.2 Adjustable Lancing Device

1.2.3 Non-adjustable Lancing Device

1.3 Blood Glucose Lancing Pen by Operation

1.3.1 Global Blood Glucose Lancing Pen Market Value Comparison by Operation: 2024 VS 2031

1.3.2 Manual Lancing Pen

1.3.3 Automatic Lancing Pen

1.4 Blood Glucose Lancing Pen by Protection Mechanisms

1.4.1 Global Blood Glucose Lancing Pen Market Value Comparison by Protection Mechanisms: 2024 VS 2031

1.4.2 Standard Pen

1.4.3 Safety Lancing Pen

1.5 Blood Glucose Lancing Pen by Application

1.5.1 Global Blood Glucose Lancing Pen Market Value by Application (2024 VS 2031)

1.5.2 Hospital

1.5.3 Clinic

1.5.4 Homecare

1.5.5 Other

1.6 Global Blood Glucose Lancing Pen Market Size Estimates and Forecasts

1.6.1 Global Blood Glucose Lancing Pen Revenue 2020-2031

1.6.2 Global Blood Glucose Lancing Pen Sales 2020-2031

1.6.3 Global Blood Glucose Lancing Pen Market Average Price (2020-2031)

1.7 Assumptions and Limitations

2 Blood Glucose Lancing Pen Market Competition by Manufacturers

2.1 Global Blood Glucose Lancing Pen Sales Market Share by Manufacturers (2020-2025)

2.2 Global Blood Glucose Lancing Pen Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Blood Glucose Lancing Pen Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Blood Glucose Lancing Pen, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Blood Glucose Lancing Pen, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Blood Glucose Lancing Pen, Product Type & Application

2.7 Global Key Manufacturers of Blood Glucose Lancing Pen, Date of Enter into This Industry

2.8 Global Blood Glucose Lancing Pen Market Competitive Situation and Trends

2.8.1 Global Blood Glucose Lancing Pen Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Blood Glucose Lancing Pen Players Market Share by Revenue

2.8.3 Global Blood Glucose Lancing Pen Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Blood Glucose Lancing Pen Market Scenario by Region

3.1 Global Blood Glucose Lancing Pen Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Blood Glucose Lancing Pen Sales by Region: 2020-2031

3.2.1 Global Blood Glucose Lancing Pen Sales by Region: 2020-2025

3.2.2 Global Blood Glucose Lancing Pen Sales by Region: 2026-2031

3.3 Global Blood Glucose Lancing Pen Revenue by Region: 2020-2031

3.3.1 Global Blood Glucose Lancing Pen Revenue by Region: 2020-2025

3.3.2 Global Blood Glucose Lancing Pen Revenue by Region: 2026-2031

3.4 North America Blood Glucose Lancing Pen Market Facts & Figures by Country

3.4.1 North America Blood Glucose Lancing Pen Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Blood Glucose Lancing Pen Sales by Country (2020-2031)

3.4.3 North America Blood Glucose Lancing Pen Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Blood Glucose Lancing Pen Market Facts & Figures by Country

3.5.1 Europe Blood Glucose Lancing Pen Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Blood Glucose Lancing Pen Sales by Country (2020-2031)

3.5.3 Europe Blood Glucose Lancing Pen Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Blood Glucose Lancing Pen Market Facts & Figures by Region

3.6.1 Asia Pacific Blood Glucose Lancing Pen Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Blood Glucose Lancing Pen Sales by Region (2020-2031)

3.6.3 Asia Pacific Blood Glucose Lancing Pen Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Blood Glucose Lancing Pen Market Facts & Figures by Country

3.7.1 Latin America Blood Glucose Lancing Pen Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Blood Glucose Lancing Pen Sales by Country (2020-2031)

3.7.3 Latin America Blood Glucose Lancing Pen Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Blood Glucose Lancing Pen Market Facts & Figures by Country

3.8.1 Middle East and Africa Blood Glucose Lancing Pen Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Blood Glucose Lancing Pen Sales by Country (2020-2031)

3.8.3 Middle East and Africa Blood Glucose Lancing Pen Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Blood Glucose Lancing Pen Sales by Type (2020-2031)

4.1.1 Global Blood Glucose Lancing Pen Sales by Type (2020-2025)

4.1.2 Global Blood Glucose Lancing Pen Sales by Type (2026-2031)

4.1.3 Global Blood Glucose Lancing Pen Sales Market Share by Type (2020-2031)

4.2 Global Blood Glucose Lancing Pen Revenue by Type (2020-2031)

4.2.1 Global Blood Glucose Lancing Pen Revenue by Type (2020-2025)

4.2.2 Global Blood Glucose Lancing Pen Revenue by Type (2026-2031)

4.2.3 Global Blood Glucose Lancing Pen Revenue Market Share by Type (2020-2031)

4.3 Global Blood Glucose Lancing Pen Price by Type (2020-2031)

5 Segment by Application

5.1 Global Blood Glucose Lancing Pen Sales by Application (2020-2031)

5.1.1 Global Blood Glucose Lancing Pen Sales by Application (2020-2025)

5.1.2 Global Blood Glucose Lancing Pen Sales by Application (2026-2031)

5.1.3 Global Blood Glucose Lancing Pen Sales Market Share by Application (2020-2031)

5.2 Global Blood Glucose Lancing Pen Revenue by Application (2020-2031)

5.2.1 Global Blood Glucose Lancing Pen Revenue by Application (2020-2025)

5.2.2 Global Blood Glucose Lancing Pen Revenue by Application (2026-2031)

5.2.3 Global Blood Glucose Lancing Pen Revenue Market Share by Application (2020-2031)

5.3 Global Blood Glucose Lancing Pen Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Roche

6.1.1 Roche Company Information

6.1.2 Roche Description and Business Overview

6.1.3 Roche Blood Glucose Lancing Pen Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Roche Blood Glucose Lancing Pen Product Portfolio

6.1.5 Roche Recent Developments/Updates

6.2 Lifescan

6.2.1 Lifescan Company Information

6.2.2 Lifescan Description and Business Overview

6.2.3 Lifescan Blood Glucose Lancing Pen Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Lifescan Blood Glucose Lancing Pen Product Portfolio

6.2.5 Lifescan Recent Developments/Updates

6.3 Abbott

6.3.1 Abbott Company Information

6.3.2 Abbott Description and Business Overview

6.3.3 Abbott Blood Glucose Lancing Pen Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Abbott Blood Glucose Lancing Pen Product Portfolio

6.3.5 Abbott Recent Developments/Updates

6.4 Ascensia

6.4.1 Ascensia Company Information

6.4.2 Ascensia Description and Business Overview

6.4.3 Ascensia Blood Glucose Lancing Pen Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Ascensia Blood Glucose Lancing Pen Product Portfolio

6.4.5 Ascensia Recent Developments/Updates

6.5 B. Braun

6.5.1 B. Braun Company Information

6.5.2 B. Braun Description and Business Overview

6.5.3 B. Braun Blood Glucose Lancing Pen Sales, Revenue and Gross Margin (2020-2025)

6.5.4 B. Braun Blood Glucose Lancing Pen Product Portfolio

6.5.5 B. Braun Recent Developments/Updates

6.6 TERUMO

6.6.1 TERUMO Company Information

6.6.2 TERUMO Description and Business Overview

6.6.3 TERUMO Blood Glucose Lancing Pen Sales, Revenue and Gross Margin (2020-2025)

6.6.4 TERUMO Blood Glucose Lancing Pen Product Portfolio

6.6.5 TERUMO Recent Developments/Updates

6.7 Sinocare

6.7.1 Sinocare Company Information

6.7.2 Sinocare Description and Business Overview

6.7.3 Sinocare Blood Glucose Lancing Pen Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Sinocare Blood Glucose Lancing Pen Product Portfolio

6.7.5 Sinocare Recent Developments/Updates

6.8 ARKRAY

6.8.1 ARKRAY Company Information

6.8.2 ARKRAY Description and Business Overview

6.8.3 ARKRAY Blood Glucose Lancing Pen Sales, Revenue and Gross Margin (2020-2025)

6.8.4 ARKRAY Blood Glucose Lancing Pen Product Portfolio

6.8.5 ARKRAY Recent Developments/Updates

6.9 GMMC Group

6.9.1 GMMC Group Company Information

6.9.2 GMMC Group Description and Business Overview

6.9.3 GMMC Group Blood Glucose Lancing Pen Sales, Revenue and Gross Margin (2020-2025)

6.9.4 GMMC Group Blood Glucose Lancing Pen Product Portfolio

6.9.5 GMMC Group Recent Developments/Updates

6.10 BIONIME

6.10.1 BIONIME Company Information

6.10.2 BIONIME Description and Business Overview

6.10.3 BIONIME Blood Glucose Lancing Pen Sales, Revenue and Gross Margin (2020-2025)

6.10.4 BIONIME Blood Glucose Lancing Pen Product Portfolio

6.10.5 BIONIME Recent Developments/Updates

6.11 LIANFA

6.11.1 LIANFA Company Information

6.11.2 LIANFA Description and Business Overview

6.11.3 LIANFA Blood Glucose Lancing Pen Sales, Revenue and Gross Margin (2020-2025)

6.11.4 LIANFA Blood Glucose Lancing Pen Product Portfolio

6.11.5 LIANFA Recent Developments/Updates

6.12 Lobeck Medical AG

6.12.1 Lobeck Medical AG Company Information

6.12.2 Lobeck Medical AG Description and Business Overview

6.12.3 Lobeck Medical AG Blood Glucose Lancing Pen Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Lobeck Medical AG Blood Glucose Lancing Pen Product Portfolio

6.12.5 Lobeck Medical AG Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Blood Glucose Lancing Pen Industry Chain Analysis

7.2 Blood Glucose Lancing Pen Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Blood Glucose Lancing Pen Production Mode & Process Analysis

7.4 Blood Glucose Lancing Pen Sales and Marketing

7.4.1 Blood Glucose Lancing Pen Sales Channels

7.4.2 Blood Glucose Lancing Pen Distributors

7.5 Blood Glucose Lancing Pen Customer Analysis

8 Blood Glucose Lancing Pen Market Dynamics

8.1 Blood Glucose Lancing Pen Industry Trends

8.2 Blood Glucose Lancing Pen Market Drivers

8.3 Blood Glucose Lancing Pen Market Challenges

8.4 Blood Glucose Lancing Pen Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Blood Glucose Lancing Pen Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Blood Glucose Lancing Pen Market Value by Operation, (US$ Million) & (2024 VS 2031)

Table 3. Global Blood Glucose Lancing Pen Market Value by Protection Mechanisms, (US$ Million) & (2024 VS 2031)

Table 4. Global Blood Glucose Lancing Pen Market Value by Application (2024 VS 2031) & (US$ Million)

Table 5. Global Blood Glucose Lancing Pen Market Competitive Situation by Manufacturers in 2024

Table 6. Global Blood Glucose Lancing Pen Sales (K Units) of Key Manufacturers (2020-2025)

Table 7. Global Blood Glucose Lancing Pen Sales Market Share by Manufacturers (2020-2025)

Table 8. Global Blood Glucose Lancing Pen Revenue (US$ Million) by Manufacturers (2020-2025)

Table 9. Global Blood Glucose Lancing Pen Revenue Share by Manufacturers (2020-2025)

Table 10. Global Market Blood Glucose Lancing Pen Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 11. Global Key Players of Blood Glucose Lancing Pen, Industry Ranking, 2022 VS 2023 VS 2024

Table 12. Global Key Manufacturers of Blood Glucose Lancing Pen, Manufacturing Sites & Headquarters

Table 13. Global Key Manufacturers of Blood Glucose Lancing Pen, Product Type & Application

Table 14. Global Key Manufacturers of Blood Glucose Lancing Pen, Date of Enter into This Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Blood Glucose Lancing Pen by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Glucose Lancing Pen as of 2024)

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Blood Glucose Lancing Pen Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 19. Global Blood Glucose Lancing Pen Sales by Region (2020-2025) & (K Units)

Table 20. Global Blood Glucose Lancing Pen Sales Market Share by Region (2020-2025)

Table 21. Global Blood Glucose Lancing Pen Sales by Region (2026-2031) & (K Units)

Table 22. Global Blood Glucose Lancing Pen Sales Market Share by Region (2026-2031)

Table 23. Global Blood Glucose Lancing Pen Revenue by Region (2020-2025) & (US$ Million)

Table 24. Global Blood Glucose Lancing Pen Revenue Market Share by Region (2020-2025)

Table 25. Global Blood Glucose Lancing Pen Revenue by Region (2026-2031) & (US$ Million)

Table 26. Global Blood Glucose Lancing Pen Revenue Market Share by Region (2026-2031)

Table 27. North America Blood Glucose Lancing Pen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 28. North America Blood Glucose Lancing Pen Sales by Country (2020-2025) & (K Units)

Table 29. North America Blood Glucose Lancing Pen Sales by Country (2026-2031) & (K Units)

Table 30. North America Blood Glucose Lancing Pen Revenue by Country (2020-2025) & (US$ Million)

Table 31. North America Blood Glucose Lancing Pen Revenue by Country (2026-2031) & (US$ Million)

Table 32. Europe Blood Glucose Lancing Pen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 33. Europe Blood Glucose Lancing Pen Sales by Country (2020-2025) & (K Units)

Table 34. Europe Blood Glucose Lancing Pen Sales by Country (2026-2031) & (K Units)

Table 35. Europe Blood Glucose Lancing Pen Revenue by Country (2020-2025) & (US$ Million)

Table 36. Europe Blood Glucose Lancing Pen Revenue by Country (2026-2031) & (US$ Million)

Table 37. Asia Pacific Blood Glucose Lancing Pen Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 38. Asia Pacific Blood Glucose Lancing Pen Sales by Region (2020-2025) & (K Units)

Table 39. Asia Pacific Blood Glucose Lancing Pen Sales by Region (2026-2031) & (K Units)

Table 40. Asia Pacific Blood Glucose Lancing Pen Revenue by Region (2020-2025) & (US$ Million)

Table 41. Asia Pacific Blood Glucose Lancing Pen Revenue by Region (2026-2031) & (US$ Million)

Table 42. Latin America Blood Glucose Lancing Pen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Latin America Blood Glucose Lancing Pen Sales by Country (2020-2025) & (K Units)

Table 44. Latin America Blood Glucose Lancing Pen Sales by Country (2026-2031) & (K Units)

Table 45. Latin America Blood Glucose Lancing Pen Revenue by Country (2020-2025) & (US$ Million)

Table 46. Latin America Blood Glucose Lancing Pen Revenue by Country (2026-2031) & (US$ Million)

Table 47. Middle East and Africa Blood Glucose Lancing Pen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 48. Middle East and Africa Blood Glucose Lancing Pen Sales by Country (2020-2025) & (K Units)

Table 49. Middle East and Africa Blood Glucose Lancing Pen Sales by Country (2026-2031) & (K Units)

Table 50. Middle East and Africa Blood Glucose Lancing Pen Revenue by Country (2020-2025) & (US$ Million)

Table 51. Middle East and Africa Blood Glucose Lancing Pen Revenue by Country (2026-2031) & (US$ Million)

Table 52. Global Blood Glucose Lancing Pen Sales (K Units) by Type (2020-2025)

Table 53. Global Blood Glucose Lancing Pen Sales (K Units) by Type (2026-2031)

Table 54. Global Blood Glucose Lancing Pen Sales Market Share by Type (2020-2025)

Table 55. Global Blood Glucose Lancing Pen Sales Market Share by Type (2026-2031)

Table 56. Global Blood Glucose Lancing Pen Revenue (US$ Million) by Type (2020-2025)

Table 57. Global Blood Glucose Lancing Pen Revenue (US$ Million) by Type (2026-2031)

Table 58. Global Blood Glucose Lancing Pen Revenue Market Share by Type (2020-2025)

Table 59. Global Blood Glucose Lancing Pen Revenue Market Share by Type (2026-2031)

Table 60. Global Blood Glucose Lancing Pen Price (US$/Unit) by Type (2020-2025)

Table 61. Global Blood Glucose Lancing Pen Price (US$/Unit) by Type (2026-2031)

Table 62. Global Blood Glucose Lancing Pen Sales (K Units) by Application (2020-2025)

Table 63. Global Blood Glucose Lancing Pen Sales (K Units) by Application (2026-2031)

Table 64. Global Blood Glucose Lancing Pen Sales Market Share by Application (2020-2025)

Table 65. Global Blood Glucose Lancing Pen Sales Market Share by Application (2026-2031)

Table 66. Global Blood Glucose Lancing Pen Revenue (US$ Million) by Application (2020-2025)

Table 67. Global Blood Glucose Lancing Pen Revenue (US$ Million) by Application (2026-2031)

Table 68. Global Blood Glucose Lancing Pen Revenue Market Share by Application (2020-2025)

Table 69. Global Blood Glucose Lancing Pen Revenue Market Share by Application (2026-2031)

Table 70. Global Blood Glucose Lancing Pen Price (US$/Unit) by Application (2020-2025)

Table 71. Global Blood Glucose Lancing Pen Price (US$/Unit) by Application (2026-2031)

Table 72. Roche Company Information

Table 73. Roche Description and Business Overview

Table 74. Roche Blood Glucose Lancing Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 75. Roche Blood Glucose Lancing Pen Product

Table 76. Roche Recent Developments/Updates

Table 77. Lifescan Company Information

Table 78. Lifescan Description and Business Overview

Table 79. Lifescan Blood Glucose Lancing Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 80. Lifescan Blood Glucose Lancing Pen Product

Table 81. Lifescan Recent Developments/Updates

Table 82. Abbott Company Information

Table 83. Abbott Description and Business Overview

Table 84. Abbott Blood Glucose Lancing Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 85. Abbott Blood Glucose Lancing Pen Product

Table 86. Abbott Recent Developments/Updates

Table 87. Ascensia Company Information

Table 88. Ascensia Description and Business Overview

Table 89. Ascensia Blood Glucose Lancing Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Ascensia Blood Glucose Lancing Pen Product

Table 91. Ascensia Recent Developments/Updates

Table 92. B. Braun Company Information

Table 93. B. Braun Description and Business Overview

Table 94. B. Braun Blood Glucose Lancing Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 95. B. Braun Blood Glucose Lancing Pen Product

Table 96. B. Braun Recent Developments/Updates

Table 97. TERUMO Company Information

Table 98. TERUMO Description and Business Overview

Table 99. TERUMO Blood Glucose Lancing Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 100. TERUMO Blood Glucose Lancing Pen Product

Table 101. TERUMO Recent Developments/Updates

Table 102. Sinocare Company Information

Table 103. Sinocare Description and Business Overview

Table 104. Sinocare Blood Glucose Lancing Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 105. Sinocare Blood Glucose Lancing Pen Product

Table 106. Sinocare Recent Developments/Updates

Table 107. ARKRAY Company Information

Table 108. ARKRAY Description and Business Overview

Table 109. ARKRAY Blood Glucose Lancing Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 110. ARKRAY Blood Glucose Lancing Pen Product

Table 111. ARKRAY Recent Developments/Updates

Table 112. GMMC Group Company Information

Table 113. GMMC Group Description and Business Overview

Table 114. GMMC Group Blood Glucose Lancing Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 115. GMMC Group Blood Glucose Lancing Pen Product

Table 116. GMMC Group Recent Developments/Updates

Table 117. BIONIME Company Information

Table 118. BIONIME Description and Business Overview

Table 119. BIONIME Blood Glucose Lancing Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 120. BIONIME Blood Glucose Lancing Pen Product

Table 121. BIONIME Recent Developments/Updates

Table 122. LIANFA Company Information

Table 123. LIANFA Description and Business Overview

Table 124. LIANFA Blood Glucose Lancing Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 125. LIANFA Blood Glucose Lancing Pen Product

Table 126. LIANFA Recent Developments/Updates

Table 127. Lobeck Medical AG Company Information

Table 128. Lobeck Medical AG Description and Business Overview

Table 129. Lobeck Medical AG Blood Glucose Lancing Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 130. Lobeck Medical AG Blood Glucose Lancing Pen Product

Table 131. Lobeck Medical AG Recent Developments/Updates

Table 132. Key Raw Materials Lists

Table 133. Raw Materials Key Suppliers Lists

Table 134. Blood Glucose Lancing Pen Distributors List

Table 135. Blood Glucose Lancing Pen Customers List

Table 136. Blood Glucose Lancing Pen Market Trends

Table 137. Blood Glucose Lancing Pen Market Drivers

Table 138. Blood Glucose Lancing Pen Market Challenges

Table 139. Blood Glucose Lancing Pen Market Restraints

Table 140. Research Programs/Design for This Report

Table 141. Key Data Information from Secondary Sources

Table 142. Key Data Information from Primary Sources

Table 143. Authors List of This Report

List of Figures

Figure 1. Product Picture of Blood Glucose Lancing Pen

Figure 2. Global Blood Glucose Lancing Pen Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Blood Glucose Lancing Pen Market Share by Type: 2024 & 2031

Figure 4. Adjustable Lancing Device Product Picture

Figure 5. Non-adjustable Lancing Device Product Picture

Figure 6. Global Blood Glucose Lancing Pen Market Value by Operation, (US$ Million) & (2020-2031)

Figure 7. Global Blood Glucose Lancing Pen Market Share by Operation: 2024 VS 2031

Figure 8. Manual Lancing Pen Product Picture

Figure 9. Automatic Lancing Pen Product Picture

Figure 10. Global Blood Glucose Lancing Pen Market Value by Protection Mechanisms, (US$ Million) & (2020-2031)

Figure 11. Global Blood Glucose Lancing Pen Market Share by Protection Mechanisms: 2024 VS 2031

Figure 12. Standard Pen Product Picture

Figure 13. Safety Lancing Pen Product Picture

Figure 14. Global Blood Glucose Lancing Pen Market Value by Application (2020-2031) & (US$ Million)

Figure 15. Global Blood Glucose Lancing Pen Market Share by Application: 2024 & 2031

Figure 16. Hospital

Figure 17. Clinic

Figure 18. Homecare

Figure 19. Other

Figure 20. Global Blood Glucose Lancing Pen Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 21. Global Blood Glucose Lancing Pen Market Size (2020-2031) & (US$ Million)

Figure 22. Global Blood Glucose Lancing Pen Sales (2020-2031) & (K Units)

Figure 23. Global Blood Glucose Lancing Pen Average Price (US$/Unit) & (2020-2031)

Figure 24. Blood Glucose Lancing Pen Report Years Considered

Figure 25. Blood Glucose Lancing Pen Sales Share by Manufacturers in 2024

Figure 26. Global Blood Glucose Lancing Pen Revenue Share by Manufacturers in 2024

Figure 27. Global 5 and 10 Largest Blood Glucose Lancing Pen Players: Market Share by Revenue in Blood Glucose Lancing Pen in 2024

Figure 28. Blood Glucose Lancing Pen Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 29. Global Blood Glucose Lancing Pen Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 30. North America Blood Glucose Lancing Pen Sales Market Share by Country (2020-2031)

Figure 31. North America Blood Glucose Lancing Pen Revenue Market Share by Country (2020-2031)

Figure 32. United States Blood Glucose Lancing Pen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Canada Blood Glucose Lancing Pen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Europe Blood Glucose Lancing Pen Sales Market Share by Country (2020-2031)

Figure 35. Europe Blood Glucose Lancing Pen Revenue Market Share by Country (2020-2031)

Figure 36. Germany Blood Glucose Lancing Pen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. France Blood Glucose Lancing Pen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. U.K. Blood Glucose Lancing Pen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Italy Blood Glucose Lancing Pen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Russia Blood Glucose Lancing Pen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Asia Pacific Blood Glucose Lancing Pen Sales Market Share by Region (2020-2031)

Figure 42. Asia Pacific Blood Glucose Lancing Pen Revenue Market Share by Region (2020-2031)

Figure 43. China Blood Glucose Lancing Pen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Japan Blood Glucose Lancing Pen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. South Korea Blood Glucose Lancing Pen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. India Blood Glucose Lancing Pen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Australia Blood Glucose Lancing Pen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. China Taiwan Blood Glucose Lancing Pen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Southeast Asia Blood Glucose Lancing Pen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Latin America Blood Glucose Lancing Pen Sales Market Share by Country (2020-2031)

Figure 51. Latin America Blood Glucose Lancing Pen Revenue Market Share by Country (2020-2031)

Figure 52. Mexico Blood Glucose Lancing Pen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Brazil Blood Glucose Lancing Pen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Argentina Blood Glucose Lancing Pen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Colombia Blood Glucose Lancing Pen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Middle East and Africa Blood Glucose Lancing Pen Sales Market Share by Country (2020-2031)

Figure 57. Middle East and Africa Blood Glucose Lancing Pen Revenue Market Share by Country (2020-2031)

Figure 58. Turkey Blood Glucose Lancing Pen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 59. Saudi Arabia Blood Glucose Lancing Pen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 60. UAE Blood Glucose Lancing Pen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 61. Global Sales Market Share of Blood Glucose Lancing Pen by Type (2020-2031)

Figure 62. Global Revenue Market Share of Blood Glucose Lancing Pen by Type (2020-2031)

Figure 63. Global Blood Glucose Lancing Pen Price (US$/Unit) by Type (2020-2031)

Figure 64. Global Sales Market Share of Blood Glucose Lancing Pen by Application (2020-2031)

Figure 65. Global Revenue Market Share of Blood Glucose Lancing Pen by Application (2020-2031)

Figure 66. Global Blood Glucose Lancing Pen Price (US$/Unit) by Application (2020-2031)

Figure 67. Blood Glucose Lancing Pen Value Chain

Figure 68. Channels of Distribution (Direct Vs Distribution)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions